Eudaimonia Partners’s Patterson-UTI PTEN Stock Holding History

Eudaimonia Partners’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-400	Closed	-$3K	–	1110
2021 Q1	$3K	Buy	+400	New	+$2.82K	﹤0.01%	1413

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JIM

JB Investments Management Phoenixville, Pennsylvania $763M AUM 110.58% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Eudaimonia Partners's PTEN Position: Q2 2021 in Review

Eudaimonia Partners sold out of Patterson-UTI (PTEN) in Q2 2021, closing a stake of 400 shares — an estimated $3K sold.

Eudaimonia Partners first reported a position in PTEN in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 214 funds tracked by Wall St. Rank hold PTEN as of Q2 2021.

Eudaimonia Partners reported no remaining Patterson-UTI position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 400 Patterson-UTI shares in Q2 2021, an estimated $3K.
Eudaimonia Partners first reported a position in Patterson-UTI in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Patterson-UTI position peaked at $3K in Q1 2021.
214 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.